Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Cutera to $1 from $3 and keeps a Neutral rating on the shares. The company reported Q2 results that fell short of consensus on the top-line, though met expectations on the bottom-line, the analyst tells investors in a research note. The firm continues to believe Cutera’s turnaround and domestic re-launch could take some time to gain traction.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUTR:
